Literature DB >> 25648874

New approaches to managing nonvalvular atrial fibrillation: what are the thromboembolic implications?

Peter J Kudenchuk1.   

Abstract

This review addresses current treatment strategies for nonvalvular atrial fibrillation (AF) and their potential impact on thromboembolic risk and complications. It updates current classification schemes for the arrhythmia and discusses specific treatment alternatives including rate control, pharmacologic rhythm suppression, catheter ablation, and left atrial appendage obliteration, each in context of thromboembolic risks and stroke prevention.

Entities:  

Mesh:

Year:  2015        PMID: 25648874     DOI: 10.1007/s11239-015-1181-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  51 in total

1.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Authors:  Sakis Themistoclakis; Andrea Corrado; Francis E Marchlinski; Pierre Jais; Erica Zado; Antonio Rossillo; Luigi Di Biase; Robert A Schweikert; Walid I Saliba; Rodney Horton; Prasant Mohanty; Dimpi Patel; David J Burkhardt; Oussama M Wazni; Aldo Bonso; David J Callans; Michel Haissaguerre; Antonio Raviele; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

Authors:  Jean-Yves Le Heuzey; Gaetano M De Ferrari; David Radzik; Massimo Santini; Junren Zhu; Jean-Marc Davy
Journal:  J Cardiovasc Electrophysiol       Date:  2010-04-06

3.  Atrial fibrillation is associated with severe acute ischemic stroke.

Authors:  Douglas A Dulli; Heather Stanko; Ross L Levine
Journal:  Neuroepidemiology       Date:  2003 Mar-Apr       Impact factor: 3.282

4.  A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions.

Authors:  Efstratios I Charitos; Ulrich Stierle; Paul D Ziegler; Malte Baldewig; Derek R Robinson; Hans-Hinrich Sievers; Thorsten Hanke
Journal:  Circulation       Date:  2012-07-23       Impact factor: 29.690

5.  Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.

Authors:  Jonas Bjerring Olesen; Gregory Y H Lip; Jesper Lindhardsen; Deirdre A Lane; Ole Ahlehoff; Morten Lock Hansen; Jakob Raunsø; Janne Schurmann Tolstrup; Peter Riis Hansen; Gunnar Hilmar Gislason; Christian Torp-Pedersen
Journal:  Thromb Haemost       Date:  2011-07-20       Impact factor: 5.249

6.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

7.  Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation.

Authors:  Hamid Ghanbari; Kazım Başer; Krit Jongnarangsin; Aman Chugh; Brahmajee K Nallamothu; Brenda W Gillespie; Hatice Duygu Başer; Arisara Suwanagool; Arisara Swangasool; Thomas Crawford; Rakesh Latchamsetty; Eric Good; Frank Pelosi; Frank Bogun; Fred Morady; Hakan Oral
Journal:  Heart Rhythm       Date:  2014-05-06       Impact factor: 6.343

8.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

9.  The history of atrial fibrillation: the last 100 years.

Authors:  Eric N Prystowsky
Journal:  J Cardiovasc Electrophysiol       Date:  2008-05-05

10.  Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update.

Authors:  O De Backer; S Arnous; N Ihlemann; N Vejlstrup; E Jørgensen; S Pehrson; T D W Krieger; P Meier; L Søndergaard; O W Franzen
Journal:  Open Heart       Date:  2014-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.